NDC 55150-433 - DEXRAZOXANE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55150-433
- Package NDCs from labels
- 55150-433-02, 55150-433-01
- Manufacturer
- Eugia US LLC | GLAND PHARMA LIMITED
- Effective date
- 2026-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DEXRAZOXANE - Eugia US LLC | GLAND PHARMA LIMITED | Eugia US LLC | GLAND PHARMA LIMITED | 2026-08-10 | Human Prescription Drug Label |
| DEXRAZOXANE - Eugia US LLC | GLAND PHARMA LIMITED | Eugia US LLC | GLAND PHARMA LIMITED | 2024-11-02 | Human Prescription Drug Label |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 6acc9f96-7088-45a7-b48f-1a861e3467ab | 2025-10-29 | Warnings, Adverse reactions | TU7HW0W0QT |
| Lactated Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | Baxter Healthcare Company | dad7735c-709b-40ea-ab7a-15577e24a966 | 2025-10-29 | Warnings, Adverse reactions | TU7HW0W0QT |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical Inc. | b96eb740-749a-4d3a-ae63-b8e3947cad30 | 2025-10-23 | Warnings, Adverse reactions | TU7HW0W0QT |
| Dexrazoxane | DEXRAZOXANE FOR INJECTION | Almaject, Inc. | 9cbd2987-10bb-eceb-153d-ee7be1ed0c84 | 2025-08-01 | Warnings, Adverse reactions | 1736590 5346058Q7S |
| Dexrazoxane | DEXRAZOXANE FOR INJECTION | Almaject, Inc. | e9550d22-6069-a6de-9968-6a18c9e0448f | 2025-08-01 | Warnings, Adverse reactions | 1736590 5346058Q7S |
| Dexrazoxane | DEXRAZOXANE | Novadoz Pharmaceuticals LLC | a7c01089-85f5-40aa-b679-f53a425b4d68 | 2025-07-31 | Warnings, Adverse reactions | 1736590 1736585 5346058Q7S |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 0956bd7c-d46f-483a-bf2c-9e11c6111ebf | 2025-07-02 | TU7HW0W0QT | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b79ef556-37b3-4fd0-8589-c633033be9df | 2025-07-02 | TU7HW0W0QT | |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | d5b85158-b0d6-4855-9d07-8d1b3ad9ab71 | 2025-06-30 | Warnings, Adverse reactions | TU7HW0W0QT |
| Dexrazoxane | DEXRAZOXANE FOR INJECTION | Gland Pharma Limited | c9c625fc-8852-4ed4-bcf2-63f46a706782 | 2025-06-23 | Warnings, Adverse reactions | 1736590 1736585 5346058Q7S |
| Dexrazoxane | DEXRAZOXANE FOR INJECTION | Fosun Pharma USA Inc. | c1d98fbe-5fd9-4518-b1a5-fac92e32928f | 2025-06-17 | Warnings, Adverse reactions | 1736590 1736585 5346058Q7S |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 67bee807-7ba8-4e92-81f2-c888118d277e | 2025-05-09 | TU7HW0W0QT | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 0fb30b7e-8e1b-49c7-afac-2d5c01b9ff45 | 2025-05-09 | TU7HW0W0QT | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b0f2c9a2-d9d4-4907-a324-e7a26d489f44 | 2025-05-09 | TU7HW0W0QT | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | a829d4eb-3ec5-453c-b270-793969af15b3 | 2025-05-09 | TU7HW0W0QT | |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | 5bf31b49-24c8-4021-98da-33a151f2fcbe | 2025-05-08 | TU7HW0W0QT | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 50fc30a0-0eca-452e-825e-08c2647ccfc1 | 2025-05-08 | TU7HW0W0QT | |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | e18bacfe-af60-49dc-bd30-cb3c29fa16db | 2025-05-07 | TU7HW0W0QT | |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | 2b327b13-a0e9-4b2c-9875-4470998e2e30 | 2025-05-07 | TU7HW0W0QT | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b2b780d3-26ac-4e7c-a0f2-78991bee32a8 | 2025-05-07 | TU7HW0W0QT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.